Celltrion Healthcare, Surge in Investor Searches... Stock Price 108,600 KRW (1.02%)
Search frequency for Celltrion Healthcare, known as the exclusive distributor of Celltrion's biosimilars, has recently surged.
As of 11:30 AM on the 11th, Celltrion Healthcare's stock price rose 1.02% from the previous day to 108,600 KRW, with a trading volume of 955,187 shares, which is about 45.83% of the 5-day average trading volume. Today, foreigners have net purchased 47,893 shares of Celltrion Healthcare, and institutions have net purchased 2,000 shares, according to provisional data.
On August 10th, Celltrion Healthcare was a market topic with the headline "Rising trend expected from biosimilar benefits."


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- Experts Shocked by Record Numbers: "Just the Tip of the Iceberg" — The Identity Behind the 90% Dominating Teens [Chuiyakgukga]⑨
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "Real-Life Elite League?" Ultra-Luxury Apartments Maple Xi and One Bailey Residents’ Exchange Event Draws Attention
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.